Login / Signup
Activated Mast Cells Combined with NRF2 Predict Prognosis for Esophageal Cancer.
Xinxin Guo
Weitao Shen
Mingjun Sun
Junjie Lv
Ran Liu
Published in:
Journal of oncology (2023)
We presume that NRF2 combined with AC-MCs could be a marker to predict prognosis and could influence immunotherapy through regulating PD-L1 in the EC.
Keyphrases
</>
oxidative stress